期刊文献+

β_2-微球蛋白在多发性骨髓瘤患者血清与尿液中的水平分析 被引量:4

下载PDF
导出
摘要 目的探讨β2-微球蛋白在多发性骨髓瘤患者血清与尿液中的表达及其与疾病发生、进展的关系。方法利用免疫比浊法检测了40例多发性骨髓瘤患者血清与尿液中的β2-微球蛋白水平。结果与健康对照者相比,多发性骨髓瘤患者血清与尿液中均含有高水平β2-微球蛋白,差异有统计学意义(P<0.01)。结论β2-微球蛋白与多发性骨髓瘤的发生、进展密切相关。
出处 《国际检验医学杂志》 CAS 2011年第14期1638-1638,共1页 International Journal of Laboratory Medicine
  • 相关文献

参考文献6

二级参考文献34

共引文献54

同被引文献47

  • 1闫若潜,李新生,夏春.乌骨鸡和珍珠鸡BF2与β微球蛋白(β2m)基因克隆及品种多态性分析[J].畜牧兽医学报,2005,36(9):861-868. 被引量:2
  • 2Bharti AC,Donato N,Aggarwal BB. Curcum in (diferuloymethane)in- hibits constitutive and IL-6-inducible STAT3 phosphorylation in hu- man multiple myeloma cells[J]. J Immuno1,2003,171 (7) : 3863-3871.
  • 3Van Camp B, Dune B G, Spier C, et al. Plasma cells in multiplemyeloma express a natural killer cell- associated antigen ; CD56(NKH-l;Leu-19) [J]. Blood,1990,76(2) : 377-382.
  • 4Bataille R, j6go G,Robillard N,et al. The phenotype of normal,reactive and malignant plasma cells. Identification of many and mul-tiple myelomas and of new targets for myeloma therapy[ J]. Haema-tologica,2006,91 (9) :1234-1240.
  • 5Damgaard T, Knudsen L M, Dahl I M, et al. Regulation of theCD56 promoter and its association with proliferation, anti-apoptosisand clinical factors in multiple myeloma [ J ]. Leuk Lymphoma,2009,50(2):236-246.
  • 6Rawstron A C,Alberto 0,Meral B, et al. Report of the EuropeanMyeloma Network on multiparametric flow cytometry in multiple my-eloma and related disorders [ J ]. Haematologica,2008, 93 ( 3 ):431-438.
  • 7Kobayashi S, Hyo R, Amitani Y, et al. Four-color flow cytometricanalysis of myeloma plasma cells [ J ]. Am J Clin Pathol,2006,126(6):908-915.
  • 8Mathew P,Ahmann G J, Witzig T E, et al. Clinicopathological cor-relates of CD56 expression in multiple myeloma : a unique entity.[J]. Br J Haematology,1995,90(2) :459-461.
  • 9Rawstron A,Barrans S,Blythe D, et al. Distribution of myelomaPlasma cells in peripheral blood andbone marrow correlates withCD56 Expression [J].Br J Haematol, 1999,104(1) : 138-143.
  • 10Pellat-Deceunynck C,Barille S, Jego G, et al. The absence ofCD56 ( NCAM) on malignant plasma cells is a hallmark of plasmacell leukemia and of a special subset of multiple myeloma[ J]. Leu-kemia 1998,12(12) :1977-1982.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部